CDER Offers Guidance on Developing Drugs for Celiac Disease

The FDA’s Center for Drug Evaluation and Research (CDER) has issued draft guidance for industry on developing medicines that can be used for the treatment of celiac disease (CeD) along with a gluten-free diet.
Source: Drug Industry Daily